Anthony Tc Chan

13PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMathematical aspects of general relativityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 10, 2026
Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma: CSCO and ASCO Joint Guideline.

|Nov 10, 2026
Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.

|Jun 17, 2026
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.

|Apr 10, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Bhumsuk Keam, Darren Wan-Teck Lim, Hsiang-Fong Kao

|Feb 03, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.

Anthony T C Chan, Victor Ho Fun Lee, Ruey-Long Hong

|Oct 08, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.

W K Jacky Lam, Brigette B Y Ma, Ann D King

Pageof 3

Frequent Collaborators

7 joint publications

Brigette Ma

4 joint publications

Wai Kei Jacky Lam

3 joint publications

Nofisat Ismaila

3 joint publications

Melvin Lk Chua